Abstract:OBJECTIVE:To investigate cytokine level in bronchoalveolar lavage fluid (BALF) in children with refractory Mycoplasma pneumoniae pneumonia (RMPP) and the effects of methylprednisolone on RMPP.METHOD:Sixty cases with RMPP and 20 cases with bronchial foreign body with no respiratory tract infection as control group hospitalized in Department of Pulmonary Diseases, the Children's Hospital Affiliated to Medical School of Zhejiang University from February 2012 to February 2013 were enrolled. The RMPP patients were divided into two groups randomly (30 cases in each). Steroid group were given methylprednisolone 2 mg/(kg·d) intravenously for 3 days, and the cases in non steroid group were not given steroid therapy. Patients whose fever relieved after steroid treatment were classified as defervesced group while the others were classified as non defervesced group. Each patient was examined with fiberoptic bronchoscopy and bronchoalveolar lavage 3 days after admission and cytokine level in BALF of each patient was detected.RESULT:(1) In steroid group, the proportion of patients whose fever disappeared within 3 days after steroid therapy was 9/30 cases (30%), and in non steroid group no one responded within 3 days after medication, showing statistically significant difference (χ² = 14.073, P=0.002), at the same time, the duration of cough in steroid group was significantly shorter than that in non steroid group (5.1 d vs. 7.0 d, t=-2.276, P=0.027). The total fever time of steroid group was 4.7 days, which as compaired with non steroid group (6.7 days) was shorter, but the difference was not significant (t=-1.351, P=0.134). (2) IL-1 β, IL-4, IL-6, IL-8, IL-10, IFN-γ in BALF of steroid group and non steroid group were both significantly higher than that of control group. But the same comparison between steroid group and non steroid group showed no significant difference. (3) In steroid group, IL-2 and IL-8 in BALF of patient whose fever disappeared after steroid therapy were both significantly lower than that of patients who still had fever (t=2.771, 2.054, P=0.010, 0.049) , but no significant difference was found between the two groups in BALF IL-1 β, IL-4, IL-6, IL-10, IFN-γ levels (P>0.05).CONCLUSION:(1) Three days of 2 mg/(kg·d) methylprednisolone therapy had the antipyretic effect in children with RMPP, and could shorten the length of cough. (2) Incresed BALF IL-1 β, IL-4, IL-6, IL-8, IL-10, IFN-γ levels were observed in RMPP and high level of BALF IL-2 and IL-8 might have some relevance with persistent fever of RMPP in children.

Efficacy and safety analysis of nebulized recombinant human interferon α1b in treatment of children with bronchiolitis

Efficacy and Safety of Recombinant Human Interferon α1b Injection Inhaling as Adjuvant Therapy for Bronchiolitis in Infants:A Systematic Review and Meta-analysis

A Multi-Center Randomized Prospective Study on the Treatment of Infant Bronchiolitis with Interferon Α1b Nebulization

Clinical Observation of Montelukast Prevention for Wheezing Infants and Young Children after Brochiolitis

Effect and security of bronchoalveolar lavage on infected atelectasis in children

Clinical observation and nursing care of children with severe hand, foot and mouth disease receiving inhalation of recombinant human interferon α-1b

Study of Interferon on Children Respiratory Infection

Effect of recombinant interferon alfa-2b on cytokine production activity of immune system cells in children with COVID-19

[Effectiveness of Methylprednisolone in Treatment of Children with Refractory Mycoplasma Pneumoniae Pneumonia and Its Relationship with Bronchoalveolar Lavage Cytokine Levels].

Safety, Tolerability, and Pharmacokinetics of Nebulized GB05-Human IFNα1b Inhalation Solution: A Randomized, Placebo-Controlled, Dose-Escalation Phase I Study in Healthy Chinese Adult Volunteers

Comparison of the efficacy of ambroxol hydrochloride and N -acetylcysteine in the treatment of children with bronchopneumonia and their influence on prognosis

Efficacy of budesonide/formoterol inhalation powder in treating viral pneumonia in children

Efficacy and safety of interferon alpha therapy in children with chronic hepatitis B: A long-term follow-up cohort study from China.

Efficacy and safety of interferon α-2b spray for herpangina in children: A randomized, controlled trial

Effect of a combination of interferon-α and ambroxol on children with pneumonia, and on serum amyloid A: A randomized controlled study

Post-infectious Bronchiolitis Obliterans in Children: Clinical Features and Bronchoalveolar Lavage Therapy

Effects of bronchoalveolar lavage on refractory Mycoplasma pneumoniae pneumonia.

Use of flow cytometry to investigate the cytokine response pattern in infants with respiratory syncytial virus infection and bronchiolitis

A Multi-Center Trial for the Efficacy of Nebulized Budesonide Inhalation in Infants and Young Children with Asthma Exacerbations

Clinical efficacy of bronchoalveolar lavage in the treatment of small airway diseases in children

Combined intravenous ribavirin and recombinant human interferon α1b aerosol inhalation for adenovirus pneumonia with plastic bronchitis in children: a case report and review of literature